|

Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients

RECRUITINGN/ASponsored by Insel Gruppe AG, University Hospital Bern
Actively Recruiting
PhaseN/A
SponsorInsel Gruppe AG, University Hospital Bern
Started2025-02-01
Est. completion2028-05-31
Eligibility
Age1 Month – 17 Years
Healthy vol.Accepted

Summary

In children and adolescents undergoing chemotherapy for cancer, fever in neutropenia (FN) is the most frequent potentially lethal complication of chemotherapy for cancer. Emergency hospitalization and empirical treatment with i.v. broad-spectrum antibiotics have reduced lethality from \>50% in certain high risk situations to \<1%. Fever without neutropenia is a further complication requiring emergency evaluation and often emergency treatment. Continuous monitoring of fever leads to earlier fever detection compared to the usual discrete fever measurements performed only for clinical reasons. Earlier detection of fever leads to earlier assessment and treatment and thus can reduce the risk of complications. This study primarily aims to assess, in pediatric patients undergoing chemotherapy for cancer, the efficacy of automated fever alerts resulting from continuous fever monitoring (CFM) using a wearable device (WD), measured by the duration of intravenous antibiotics (i.v. AB) given for any cause.

Eligibility

Age: 1 Month – 17 YearsHealthy volunteers accepted
Inclusion Criteria:

* Chemotherapy treatment because of any malignancy expected to last ≥2 months at time of recruitment for myelosuppressive therapy, or at least 1 cycle of myeloablative chemotherapy followed by hematopoietic stem cell transplantation
* Age ≥1 month and \<18 years at time of recruitment
* Written informed consent from patients and/or parents

Exclusion Criteria:

* Neonates \<1 months
* Local skin disease prohibiting wearing of the WD
* Denied written informed consent from patients and/or parents
* Inclusion of vulnerable participants mandatory as vital signs and FN episodes differ significantly in children and adults

Conditions2

CancerPediatric Oncology Patients With Risk for Infections

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.